Dianthus Therapeutics Inc
NASDAQ:DNTH

Watchlist Manager
Dianthus Therapeutics Inc Logo
Dianthus Therapeutics Inc
NASDAQ:DNTH
Watchlist
Price: 40.96 USD -1.59% Market Closed
Market Cap: 1.8B USD

Intrinsic Value

The intrinsic value of one DNTH stock under the Base Case scenario is hidden USD. Compared to the current market price of 40.96 USD, Dianthus Therapeutics Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

DNTH Intrinsic Value
HIDDEN
Show
Base Case Scenario

Valuation History
Dianthus Therapeutics Inc

Intrinsic Value History
Dive into the past to invest in the future

DNTH looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether DNTH usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about DNTH?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is DNTH valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Dianthus Therapeutics Inc.

Explain Valuation
Compare DNTH to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about DNTH?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Dianthus Therapeutics Inc

Current Assets 413.8m
Cash & Short-Term Investments 402.6m
Receivables 5m
Other Current Assets 6.2m
Non-Current Assets 163.6m
Long-Term Investments 152.9m
PP&E 1.5m
Other Non-Current Assets 9.3m
Current Liabilities 23.9m
Accounts Payable 6.7m
Accrued Liabilities 16.2m
Other Current Liabilities 954k
Non-Current Liabilities 7.1m
Other Non-Current Liabilities 7.1m
Efficiency

Free Cash Flow Analysis
Dianthus Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Dianthus Therapeutics Inc

Revenue
3.1m USD
Operating Expenses
-143.4m USD
Operating Income
-140.3m USD
Other Expenses
14m USD
Net Income
-126.3m USD
Fundamental Scores

DNTH Profitability Score
Profitability Due Diligence

Dianthus Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

ROIC is Increasing
ROE is Increasing
Low 3Y Average Gross Margin
Low Gross Margin
hidden
Profitability
Score

Dianthus Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

DNTH Solvency Score
Solvency Due Diligence

Dianthus Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
hidden
Solvency
Score

Dianthus Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

DNTH Price Targets Summary
Dianthus Therapeutics Inc

Wall Street analysts forecast DNTH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DNTH is 68.77 USD with a low forecast of 46.46 USD and a high forecast of 105 USD.

Lowest
Price Target
46.46 USD
13% Upside
Average
Price Target
68.77 USD
68% Upside
Highest
Price Target
105 USD
156% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dianthus Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for DNTH is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

DNTH Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one DNTH stock?

The intrinsic value of one DNTH stock under the Base Case scenario is hidden USD.

Is DNTH stock undervalued or overvalued?

Compared to the current market price of 40.96 USD, Dianthus Therapeutics Inc is hidden .

Back to Top